The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 01, 2005
Filed:
Sep. 27, 2001
Clare J Watkins, Abingdon, GB;
Maria Rosario Romero-martin, Didcot, GB;
Paul W Finn, Abingdon, GB;
Ivars Kalvinsh, Riga, LV;
Einars Loza, Riga, LV;
Daina Lolya, Riga, LV;
Igor Starchenkov, Riga, LV;
Rasma M Bokaldere, Riga, LV;
Valentina Semenikhina, Riga, LV;
C. John Harris, Sittingbourne, GB;
James E. S. Duffy, Sittingbourne, GB;
Clare J Watkins, Abingdon, GB;
Maria Rosario Romero-Martin, Didcot, GB;
Paul W Finn, Abingdon, GB;
Ivars Kalvinsh, Riga, LV;
Einars Loza, Riga, LV;
Daina Lolya, Riga, LV;
Igor Starchenkov, Riga, LV;
Rasma M Bokaldere, Riga, LV;
Valentina Semenikhina, Riga, LV;
C. John Harris, Sittingbourne, GB;
James E. S. Duffy, Sittingbourne, GB;
TopoTarget UK Limited, Abingdon, GB;
Abstract
This invention pertains to certain active carbamic acid compounds which inhibit HDAC activity and which have the following formula:wherein: A is an aryl group; Qis a covalent bond or an aryl leader group; J is an amide linkage selected from: —NRC(═O)— and —C(═O)NR—; Ris an amido substituent; X is an ether heteroatom, and is —O— or —S—; and, Rand Rare each independently an ether group; and pharmaceutically acceptable salts, solvates, amides, esters, ethers, chemically protected forms, and prodrugs thereof. The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit HDAC, and, e.g., to inhibit proliferative conditions, such as cancer and psoriasis.